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Abstract
Background: There are increasing examples of linking data on healthcare resource use and patient outcomes from
different sectors of health and social care systems. Linked data are generally anonymised, meaning in most
jurisdictions there are no legal restrictions to their use in research conducted by public or private organisations.
Secondary use of anonymised linked data is contentious in some jurisdictions but other jurisdictions are known for
their use of linked data. The publics’ perceptions of the acceptability of using linked data is likely to depend on a
number of factors. This study aimed to quantify the preferences of the public to understand the factors that
affected views about types of linked data and its use in two jurisdictions.
Method: An online discrete choice experiment (DCE) previously conducted in Scotland was adapted and replicated
in Sweden. The DCE was designed, comprising five attributes, to elicit the preferences from a representative sample
of the public in both jurisdictions. The five attributes (number of levels) were: type of researcher using linked data
(four); type of data being linked (four); purpose of the research (three); use of profit from using linked data (four);
who oversees the research (four). Each DCE contained 6 choice-sets asking respondents to select their preferred
option from two scenarios or state neither were acceptable. Background questions included socio-demographics.
DCE data were analysed using conditional and heteroskedastic conditional logit models to create forecasts of
acceptability.
Results: The study sample comprised members of the public living in Scotland (n = 1004) and Sweden (n = 974).
All five attributes were important in driving respondents’ choices. Swedish and Scottish preferences were mostly
homogenous with the exception of ‘who oversees the research using linked data’, which had relatively less impact
on the choices observed from Scotland. For a defined ‘typical’ linked data scenario, the probability (on average) of
acceptance was 85.7% in Sweden and 82.4% in Scotland.
Conclusion: This study suggests that the public living in Scotland and Sweden are open to using anonymised
linked data in certain scenarios for research purposes but some caution is advisable if the anonymised linked data
joins health to non-health data.
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Background
The process of producing linked datasets is defined as
“the bringing together from two or more different
sources, data that relate to the same individual, family,
place or event” [1]. There are increasing examples of
linking data on healthcare resource use and patient out-
comes from different sectors of health and social care
systems and potentially with data outside of health
(linked data). For example, data from hospital admis-
sions can be linked with medical records held by general
practitioners (GPs) or more generally linking data from
hospital medical records with national mortality data.
Such linked data has been used to investigate the associ-
ation between diabetes and cancer [2] or understand the
hazards of discontinuing certain medications after an
acute myocardial infarction [3]. It is also possible to link
data from the health care sector with data from other
sources, such as social care or education [4]. This
broadens the types of research questions that can be
addressed; for example, data from GP records linked
with government data have been used to investigate
the relationship between epilepsy diagnoses and social
deprivation [5].
Research using linked data generally uses anonymised
data, where data have been converted so that individuals
can no longer be identified within the final dataset [6].
This process of producing anonymised linked data can
occur before anonymization or by using a common iden-
tifier across the datasets comprising the linked data. In
many jurisdictions, there are no legal restrictions to the
use of such anonymised linked data, even in the absence
of explicit patient consent. One example jurisdiction,
Sweden, is famous for the extent of its use of national
registries of anonymised linked data, and the universal
unique personal identity number that makes data linkage
comparatively straightforward [7, 8]. Despite the legality
of using anonymised linked data, use of such data for
purposes other than the original use for which the data
were collected (‘secondary use’) has become contentious
in some jurisdictions. Public objections have resulted in
the failure of national data science initiatives in England
[9] and Australia [10], for example.
There is also evidence of heterogeneity in views about
the use of anonymised linked data within countries. Evi-
dence suggests that some people are willing to give a
general consent for using anonymised linked data but
others are content not to be asked for consent provided
that the data are used in studies that have been reviewed
and approved by an ethics committee [11]. Published
systematic reviews indicate the majority of the existing
evidence on the preferences of the public about using
anonymised linked data comes from the United
Kingdom (UK) and particularly Scotland [12, 13]. Rela-
tively little empirical research has been conducted to
understand the preferences of the public from jurisdic-
tions such as Sweden, which has widespread collection
and use of anonymised linked data [7, 8]. Kodate con-
ducted secondary analysis of media articles published in
Swedish newspapers between 1995 and 2005 and identi-
fied that the media made frequent calls for improving
the quality assurance systems underpinning the use and
reporting of data from national registries [14].
Three published systematic reviews have summarised
the literature that aims to understand the attitudes of
members of the public to the use of linked data [12, 13,
15]. The individual studies identified in these systematic
reviews were largely conducted in a single country, or a
single region of a country, and there was a paucity of
studies making a comparison between jurisdictions.
There is some evidence that preferences may differ be-
tween jurisdictions. The European Commission’s Special
Eurobarometer on Data Protection in 2011, reported
that 66% of people living in Sweden were unconcerned
about unnecessary disclosure of personal information
compared with 19% of people living in the UK [16]. Fur-
thermore, the majority (63%) of people living in Sweden
were unconcerned about the secondary use of data com-
pared with 20% of people living in the UK.
There are published examples of quantitative studies
designed to collate views of the public about using anon-
ymised linked data exist but these studies have tradition-
ally used opinion-based survey or Likert-style agreement
questions [13, 17–19], which are limited in their ability
to identify the factors driving preferences. Questions
which require rating or ranking may reveal individuals’
order of preference, but they are not able to quantify dif-
ferences in magnitude of preference. For example,
people may clearly prefer apples to oranges and on a
traditional survey question may give apples all five marks
and oranges only three marks, or rank apples before or-
anges in a list. From these rating, you can elicit the order
of preference, but it is not always possible to understand
how much better apples are than oranges, or how many
oranges an individual would exchange for an apple.
Similarly, it does not reveal when increases in apples are
no longer satisfying to an individual; perhaps when the
individual has 10 apples, they would prefer an orange.
Discrete choice experiments (DCEs) are a stated pref-
erence method which aim to elicit and quantify the pref-
erences of a sample of the population for a specified
service or product described by a set of characteristics
(attributes and levels) [20]. A DCE takes account of the
opportunity cost when making such choices as people
have to make trade-offs between the attributes when
they choose their preferred scenario from a set of hypo-
thetical scenarios called ‘choice-sets’ [20]. In each
choice-set, the respondent is presented with options de-
scribed by the same attributes in varying amounts
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(levels) [21]. Under the theory of random utility maxi-
misation (see Appendix), it is assumed that individuals
choose the option which would provide them with the
most value (‘utility’) and thus the choices made reveal
both their preferences and the relative importance of
each attribute when making their choice [22]. With the
estimates of utility, is also possible to calculate the ex-
pected return and forecast from the collected data to es-
timate the probability of an individual choosing a
particular scenario over another. DCEs are increasingly
used to quantify people’s preferences for health goods,
services and interventions, where normal markets rarely
exist [23–26]. Although the number of studies in health
economics is growing, applications started in the 1990s,
making the approach relatively new compared to other
question formats. Consensus-based guidelines on best
research practice have been produced by the Inter-
national Society for Pharmacoeconomics and Outcomes
Research (ISPOR) for researchers seeking to use DCEs
to quantify preferences in a healthcare context [27–29].
The aim of this study was to identify and compare the
factors most influential in shaping public preferences, in
two exemplar jurisdictions, for the type and use of linked
data in a research context.
Methods
This study used an online survey to field a DCE to com-
pare the preferences of a sample of the public represent-
ing two jurisdictions (Scotland and Sweden). The
Scottish DCE was conducted in 2016 [30]; this study
replicated that DCE in Sweden, to enable comparisons
between the two jurisdictions.
The DCE design and analysis are reported in line with
published guidance [20, 29]. The online survey com-
prised four sections: an initial page of narrative introdu-
cing key concepts, and rationale for the sharing and use
of anonymised linked data; questions about attitude to
sharing and use of anonymised linked data; the choice-
sets that formed the DCE; and socio-demographic
questions.
Conceptualising the choice question
The DCE used two ‘unlabelled’ alternatives to present
scenarios describing the type and use of anonymised
linked data. Respondents were asked to select which, if
any, of the two alternatives was their preferred option.
Respondents could also indicate if neither of the two al-
ternatives was acceptable, allowing respondents the op-
tion to ‘opt-out’. Figure 1 shows an example choice-set.
Attribute and level selection
Each alternative scenario was described with five attri-
butes and plausible levels (see Table 1). For all but one
attribute, there were four levels; the remaining attribute
(research purpose) had three levels as there was no
meaningful fourth level. Detail of the identification and
generation of the five attributes and their levels has been
published previously in relation to the original Scottish
DCE [30]. Briefly, the attributes were chosen as the most
important characteristics of sharing and using linked
data of concern to the public, based on qualitative
Fig. 1 Example of scenario choice
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research [31] and a systematic review of the literature on
public attitudes to linked data [12]. The levels were chosen
to represent a range of actual or potential variations in
these attributes and set to be within realistic and meaning-
ful ranges to represent how linked data could be poten-
tially shared and used. The wording of the attributes and
levels was refined through iterations and engagement with
members of an existing public involvement panel (the Farr
Institute Scotland Public Panel).
Experimental design
There were 768 (44 × 31) unique profiles possible from the
chosen attributes and levels, which could create 294,528
different combinations for the choice-tasks. To reduce this
unmanageable number of potential alternatives, a main ef-
fects design was generated using Sawtooth Software [32]
with each respondent allocated to one of 40 blocks each
containing six choice-sets. The paired alternatives selected
by the software were reviewed to remove irrational or im-
plausible choice sets. Pilot testing in Scotland revealed that
using 12 choice-sets resulted in respondent fatigue, hence
each respondent was presented with six choice-sets in a
random order in the main survey [30].
Survey design and piloting
The DCE was embedded as part of an online survey, as
described earlier. The Swedish DCE used the same de-
sign as that used previously in Scotland, with appropri-
ate changes for the different organisational health care
systems. Forward and backward translation was con-
ducted by an independent organisation and validated by
bilingual members of the research team. Each survey
was tested, using qualitative piloting in interviews in
each country, with a convenience sample of 20 people of
Table 1 Attributes and Levels
Attribute Levels (text variation for Sweden in brackets)
The researchers are: Only university researchers.
Only university researchers or NHS staff (researchers employed by a county council).
Only university researchers, NHS staff or government researchers (researchers employed
by a county council or researchers employed by one of the authorities).
University researchers, NHS staff, government researchers (researchers employed by a
county council or researchers employed by one of the authorities) and commercial
researchers such as market research organisations or pharmaceutical companies.a
The type of data being linked: Information from your GP (primary care) records being linked with information from
your other NHS (county council) health records e.g. hospital records.
Information from your NHS (county council) health records being linked with information
from your social care or education records.
Information from your NHS (county council) health records being linked with information
from your social care or education records, or from your employment and benefits (national
health insurance) records.
Information from your NHS (county council) health records being linked with information
from your social care, education, employment, and benefits (national health insurance)
records, as well as information collected about you in the private sector e.g. through
online shopping accounts. a
The purpose of the research: Research using linked information should only be conducted if it will have direct benefits
for the people whose information is being used.
Research using linked information should only be conducted if it will have general public benefits.
Research using linked information should be allowed for any reason.a
Profit-Making: Nobody should be allowed to profit from research carried out using linked information.
Any profit made from research carried out using linked information should be shared with the public.
Any profit made from research carried out using linked information should be invested into public services.
Any profit made from research carried out using linked information should be kept by those carrying
out the research. a
Oversight: The process should be overseen by the Scottish (Swedish) Government.
The process should be overseen by a non-governmental independent body (an independent body that is
not part of the Swedish Government).
The process should be overseen by the relevant public service(s); for example, research that uses information
from people’s health records should be overseen by the NHS (county council).
The process should be overseen by the organisations undertaking the research. a
a base level in the analysis
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a variety of ages and gender. The aims of the qualitative
pilot were to ensure respondents understood the in-
structions and the language used, and to test how they
interacted with the survey and how long they took to
complete it. Minor changes were made to the ordering
and wording of some questions in Scotland for improved
clarity [30] and these were carried forward to the
Swedish survey where no additional changes were needed.
Study population and sampling frame
The relevant study population for this study were adult
(18 years and over) members of the public from two se-
lected example jurisdictions (Scotland and Sweden).
Scotland was chosen as an exemplar because National
Health Service (NHS) Scotland is a publicly funded
health care system that has the capacity to share and use
anonymised linked data. Sweden was chosen as a com-
parator because the use of linked data is relatively more
common, with large national registries integrating health
and other social data used to answer a range of research
questions. The two jurisdictions have comparable uni-
versal healthcare coverage by either national (the NHS
in Scotland) or local (county councils in Sweden) pro-
viders, respectively.
For a DCE, the required sample size depends on the
number of choice-sets, the number of alternatives in a
choice set, and the number of levels attached to an attri-
bute [33]. Given these characteristics, and the objectives
to explore preference heterogeneity and compare the re-
sponses between Scotland and Sweden, a sample of 1000
respondents from each country was deemed more than
sufficient for this study. In this DCE, the power calcula-
tion for sample size suggested by Orme would indicate a
minimum sample size of 167 [33]. This power calcula-
tion, however, does not make allowances for investiga-
tions into preference heterogeneity nor the difference in
preferences between Sweden and Scotland. A published
review of sample sizes in DCEs found that, out of 505
healthcare DCE studies, only six had sample sizes of
over 1000 [34].
The DCE was sent to a sample of adult members of
the public in the two countries (Scotland and Sweden).
The sample was identified using an international market
research company, Ipsos [35] (called Ipsos Mori in the
UK), who provide members of online panels [36]. Partic-
ipants were members of the Ipsos international panel
(called i-Say), who had volunteered to take part in regu-
lar market research surveys. Panellists received regular
invitations from Ipsos to participate in surveys and were
free to decide whether to complete any individual sur-
vey. Panellists were selected at random, and invited to
take part via an email, with quotas set on key demo-
graphic variables, namely, age, gender, and working sta-
tus, with the aim of achieving a sample of 1000 people
in each country who were representative of the popula-
tion for these criteria. The Scottish survey was con-
ducted in August 2016 and the Swedish survey in June
2017; both were live for 14 days, until the quotas were
filled.
Screening questions were used at the start of the sur-
vey, based on the attributes and levels. For example, re-
spondents were asked which of the levels in the attribute
“the purpose of research” was closest to their view, along
with the option to select that “data linkage should not
be permitted under any circumstances”. Respondents
selecting the latter were routed-out and did not
complete the DCE [30]. It was hypothesised that these
respondents would always select the opt-out option. Re-
moving them from the sample ensured that DCE re-
spondents did not fundamentally object to data linkage
and thus allowed an investigation of the nuanced public
preferences for conducting research with linked data.
Analysis
Choice data from the DCE were analysed using discrete
choice models. All attributes were categorical and were
dummy coded relative to a base level (Table 1) that was
deemed to be the ‘worst’. The primary analysis estimated
the preferences from each sample of respondents from
the two countries separately using a conditional logit
model. To further compare data between Scotland and
Sweden, a pooled conditional logit model was estimated
with interaction terms between dummy variables that
identified the respondent’s nationality (1 = Scottish) and
each attribute level. To account for differences in scale,
a pooled heteroskedastic conditional logit model with
these same interactions was also estimated [37, 38]. The
scale parameter was allowed to vary by the respondent’s
nationality. In order to identify the scale term, prefer-
ences over one attribute must be restricted to be equal
across countries. This attribute (purpose of the research)
was selected based on statistically insignificant inter-
action terms in the pooled conditional logit model. All
analyses were completed using Stata 13 [39].
The probability of an individual finding a specific sce-
nario acceptable was calculated by estimating the ex-
pected observable utility of an alternative and comparing
it with expected utility of another. A ‘typical’ linked data
scenario was defined as university researchers or health
service staff using linked health records for general pub-
lic benefit, the profit is invested in public services and
the process is overseen by the relevant public services.
Two scenarios were then specified as: best-case (the
most risk averse scenario, where only university re-
searchers use linked data from health records for the
benefit of people whose data are being used, there is no
profit made and the process is overseen by a non-
governmental body) and worst-case (where university
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researchers, health service staff, government and com-
mercial researchers use health data linked to social care,
education, employment and private sector data for re-
search with any purpose, where the profit is kept by
those carrying out these research who also oversee the
process). Investigations into preference heterogeneity
were conducted using a split sample analysis and com-
paring the probabilities of scenarios being acceptable.
Results
A total of 1978 respondents completed the survey and
were included in the analysis (Table 2). An additional
974 respondents (461 in Scotland and 513 in Sweden)
started the survey but were routed-out at the initial
questions (presented in the order shown in Table 3) be-
cause they stated that sharing or using linked data was
unacceptable under any conditions.
The results of the conditional logit model (Table 4)
suggested that all attribute levels were statistically sig-
nificant (p < 0.01). The positive coefficients indicated
that all levels were preferred, relative to the ‘worst’ level
of each attribute that were used as a ‘base level’. The ab-
solute values of the estimated coefficients cannot be
interpreted as pure ‘preference weights’ because these
estimated values measure relative preference [27] and,
therefore, only the relative sizes of changes across levels,
in each country, have meaningful interpretations.
The positive interaction terms between levels and na-
tionality could suggest that Scottish respondents have
stronger preferences over using linked data than those
living in Sweden. However, the inflated coefficients for
Scotland may be driven by differences in scale (choice
consistency). Table 5 shows the results of the heteroske-
dastic conditional logit model with interaction and scale
terms. These results show that the scale term was statis-
tically significant at the 10% level (p = 0.052) which can
be interpreted to indicate that the Scottish sample were,
on average, more ‘consistent’ in their decision making
when making choices. The estimated error term (the
variance of the unobservable element of utility) was
smaller in the Scottish sample relative to the Swedish
sample. The statistically significant and positive constant
term also suggests that, all else being equal, respondents
preferred their data not to be used or linked.
The attribute for the source of data being linked
aligned with a priori expectations as respondents pre-
ferred fewer sources of data being linked in both coun-
tries. On average, respondents generally preferred
different types of health records being linked together
rather than health records linked with public social, edu-
cation or employment records, although all of these sce-
narios were preferable to linkage with private sector
records (the base case). Respondents in both countries
preferred that nobody profits rather than the profits go
to those carrying out the work. However, people in both
countries, on average, preferred profit to be invested into
public services or shared with the public than nobody
profiting at all.
For the attributes ‘who does the research’, ‘type of data
being linked’ and ‘profit-making’, average preferences be-
tween the two countries were relatively homogenous.
Similarly, the constant term did not significantly differ
between the groups indicating respondents in one coun-
try were no more or less likely to state that neither sce-
nario was acceptable. The most prominent difference in
preferences between Scotland and Sweden were for the
attribute ‘oversight’ (see Table 5). Although, on average,
respondents in both countries preferred external over-
sight of the research, the respondents living in Sweden
seemed to value this as being more important, as it had
a larger impact on their choice-making.
For the typical data linkage scenario, the probability of
acceptance, on average, was 85.7% in Sweden and 82.4%
in Scotland. In the ‘best-case’ scenario of data linkage,
the probability, on average, of a Swedish person








Male 421 (41.9%) 499 (51.2%)
Female 583 (58.1%) 475 (48.8%)
Age
18–34 years 275 (27.4%) 354 (36.3%)
35–54 years 358 (35.7%) 411 (42.2%)
55+ years 371 (37.0%) 209 (21.5%)
Employment a
Working part or full time 557 (55.5%) 627 (64.3%)
Not working 444 (44.2%) 341 (35.0%)
a missing data: Scotland (n = 3) and Sweden (n = 6)
Table 3 Number of respondents routed-out after responding
“data linkage should not be permitted under any
circumstances” to the initial survey questions
Initial survey questions, in ordera Scotland (n) Sweden (n)
Purposes of research 67 51
Who are the researchers 104 186
What types of information may be linked 135 128
Management of potential profits 145 140
Arrangements for oversight/monitoring 8 5
Public involvement in data linkage research 2 3
Total 461 513
aEach question asked respondents which of the levels in Table 1 was closest
to their view about the attribute (or that data linkage should not
be permitted)
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accepting the alternative was estimated to be 75.0%
compared with 72.1% in Scotland. In the ‘worst-case’,
the probability of the scenario being acceptable on aver-
age, was 35.0% in both countries. Figure 2 shows the
probability of these different scenarios being acceptable
in different subgroups of the sample. Differences in ac-
ceptability of the ‘worst-case’ scenario were most prom-
inent when considering gender, with men 50% more
likely to find this case of data linkage acceptable com-
pared to women (44 and 27% retrospectively).
An interactive model showing average probability of
acceptability in different scenarios is available in the on-
line supplementary materials (see Additional file). This
allows the reader to see the impact of changing attribute
levels on the average probability of acceptability of, for
example, the typical scenario. Changing the research
attribute to the base level, ‘research for any reason’ (and
keeping all others the same) decreased the probability of
acceptance of the typical scenario by 6.1 and 7.1% in
Sweden and Scotland respectively. In comparison, chan-
ging only the type of data attribute to the base level of
‘health data linked to social care, education, employment
and private-sector data’ decreased the probability of the
scenario being accepted by 11.0 and 12.6% in the two
jurisdictions.
Discussion
This study quantified the aspects of sharing and using
different types of linked data that drove the preferences
of members of the public and estimated the potential
impact on acceptability of using anonymised linked data.
It is the first study to directly compare preferences for
Table 4 Results of the conditional logit model
Attribute and level Estimate coefficient
(standard error)
Scotland Sweden Country comparisonb
Researchers:
University researchers 0.214*** (0.05) 0.168** (0.05) 0.047 (0.07)
University /health service staff 0.500*** (0.05) 0.312*** (0.05) 0.188** (0.07)
University/health service staff/government 0.445*** (0.05) 0.337*** (0.05) 0.108 (0.07)
University/health service staff/government/commercial2 Base levela
Data to be linked:
Primary care linked to other health records 0.918*** (0.05) 0.706*** (0.05) 0.212** (0.07)
Health records linked to social care/education records 0.664*** (0.05) 0.403*** (0.05) 0.261*** (0.07)
Health records linked to social care/education/employment/benefits records 0.407*** (0.05) 0.171*** (0.05) 0.236** (0.07)
Health records linked to social care/education/ employment/benefits records/private sector Base levela
Purpose:
Direct benefits for the people whose information is used 0.322*** (0.04) 0.254*** (0.04) 0.068 (0.06)
Research conducted if it will have general public benefits 0.548*** (0.04) 0.430*** (0.04) 0.118* (0.06)
Research for any reason Base levela
Profit-making:
Nobody profits 0.326*** (0.05) 0.171*** (0.05) 0.156* (0.07)
Profit shared with the public 0.579*** (0.05) 0.397*** (0.05) 0.182* (0.07)
Profit invested into public services 0.739*** (0.05) 0.506*** (0.05) 0.233** (0.07)
Profit goes to those doing the research Base levela
Oversight:
Overseen by independent body 0.346*** (0.05) 0.420*** (0.05) −0.074 (0.07)
Overseen by relevant public service 0.265*** (0.05) 0.457*** (0.05) −0.192** (0.07)
Overseen by Government 0.066 (0.05) 0.289*** (0.05) −0.223** (0.07)
Overseen by the organisation undertaking the research Base levela
Constant 0.886*** (0.08) 0.620*** (0.08) 0.266* (0.12)
Number of observations 18,072 17,532 35,604
*p < 0.05; **p < 0.01; ***p < 0.001
a Each attribute used categorical levels, which were dummy coded relative to a base level (Table 1) that was deemed to be the ‘worst’
b The country comparison model, estimated using pooled data using a condition logit model, included interaction terms between dummy variables that identified
the respondent’s nationality (1 = Scottish) and each attribute level
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Table 5 Results of the heteroskedastic conditional logit model
Attribute and level Estimate coefficient (standard error)
Pooled data (Scotland and Sweden) Interaction termsb
Researchers:
University researchers 0.168** (0.05) 0.001 (0.07)
University /health service staff 0.312*** (0.05) 0.080 (0.08)
University/health service staff/government 0.337*** (0.05) 0.012 (0.08)
University/health service staff/government/commercial Base levela
Data to be linked:
Primary care linked to other health records 0.706*** (0.05) 0.014 (0.11)
Health records linked to social care/education records 0.403*** (0.05) 0.118 (0.09)
Health records linked to social care/education/employment/benefits records 0.171*** (0.05) 0.148 (0.08)
Health records linked to social care/education/ employment/benefits records/private sector Base levela
Purpose:
Direct benefits for the people whose information is used 0.253*** (0.03) 0c
Research conducted if it will have general public benefits 0.430*** (0.04) 0c
Research for any reason Base levela
Profit-making:
Nobody profits 0.171*** (0.05) 0.086 (0.07)
Profit shared with the public 0.397*** (0.05) 0.057 (0.08)
Profit invested into public services 0.506*** (0.05) 0.074 (0.09)
Profit goes to those doing the research Base levela
Oversight:
Overseen by independent body 0.420*** (0.05) −0.148* (0.07)
Overseen by relevant public service 0.457*** (0.05) −0.249*** (0.07)
Overseen by Government 0.289*** (0.05) −0.238*** (0.07)
Overseen by the organisation undertaking the research Base levela
Constant 0.620*** (0.08) 0.076 (0.11)
Scale term (if the respondent is Scottish) 0.242 (0.12)
Number of observations 35,604
*p < 0.05; **p < 0.01; ***p < 0.001
a Each attribute used categorical levels, which were dummy coded relative to a base level (Table 1) that was deemed to be the ‘worst’
b Interaction terms indicate the effect of being Scottish on the estimated coefficients
c The estimated model included an interaction term in which the attribute ‘purpose’ was restricted to zero
Fig. 2 Probability of a scenario describing linked data being acceptable
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the sharing and use of linked data between two coun-
tries, showing that there were considerable similarities in
average preferences amongst members of the public in
Scotland and Sweden. The exception to these common
preferences was that people living in Sweden were more
influenced by who should have control of ‘external over-
sight’ when sharing or using linked data.
The considerable similarities between preferences in
the two jurisdictions are curious, given the perceived
differences in the use of linked data between the two
countries. In Sweden, the use of a unique personal
identifier means that the creation and use of registries
of data are common [7, 8] but this is less so in
Scotland. However, Scotland is distinct from the rest
of the UK in that, since the 1970s, all NHS patients
have been assigned a Community Health Index num-
ber which registers data on address, postcode, GP,
date of birth, region of registration and date of death.
This is used in all primary health care activities and
hospital-based clinical information systems, through-
out NHS Scotland, including the Emergency Care
Summary. Nevertheless, the lack of a universal per-
sonal identifier reduces the ease with which data from
different sectors can be linked. Throughout the UK,
health data science research is increasing [40] and
there is an increasing move towards data use and
linkage across sectors where “Data will drive
Scotland’s next economic revolution” [41]; knowledge
of public preferences and acceptability will be vital in
ensuring that there is a social license for such work
[9]. Therefore, it is reassuring that the preferences in
Scotland are so similar to those in a jurisdiction
where data use and linkage are perceived as both
commonplace and acceptable.
The main differences between the two jurisdictions
related to external oversight of data use and linkage.
Swedish respondents were more likely to prefer over-
sight by either the government or the relevant public
service, or, to a lesser extent, an independent body
(Table 5) than were the Scottish respondents. Swedish
national data registries are tightly controlled and their
use requires review both by ethics committees and
the government organisation Statistics Sweden [8]. In
addition, the delivery of healthcare is devolved locally
and one study found that Swedes were more likely to
want to be involved in local healthcare organisations
then were people in England [42]. However, such
oversight is not always valued in Sweden. In one
study on public perceptions of biobank research, re-
spondents did not trust either the government or
county councils to evaluate the risks and benefits of
genetic research being proposed [43].
The “best case” scenario chosen in this study was the
most risk averse scenario. However, the average
probability of this being accepted (over 70% in both
jurisdictions) was less than that of the typical sce-
nario, where the average probability of it being ac-
cepted was over 80%. This typical scenario was
chosen to be similar to much of the health research
conducted with linked data, such as that cited earlier
[2, 3]. Previous studies have suggested that public
benefit is potentially a key condition for acceptability
of research using linked data [12, 44, 45]. However,
changing this single attribute to the base case (‘re-
search for any reason’) decreased the probability of
acceptance of the scenario by only 6–7%. In compari-
son, changing only the type of data that were linked
to the base level (linkage of multiple types of public
and private sector data) decreased the probability of
the scenario being accepted by almost twice as much.
When considered individually in surveys, the purpose
of the research, particularly for research involving
commercial companies, has been shown to be import-
ant for public acceptability of the research [12, 44,
45]. Those studies were limited in their abilities to
compare factors that influence acceptability. This
study has been able to quantify the differences in ac-
ceptability between such factors and this suggests that
public benefit may be slightly less important to re-
spondents than the types of data that were being
linked.
Multiple types of data linked together, as with the
base case, may be of concern to respondents because
this is currently an unfamiliar consideration within
data linkage. Some members of the public (33%) in
the UK are very aware that the NHS uses health data
in research, but much fewer (16%) are aware that
commercial companies also do so [44]. By extrapola-
tion, it would be expected that even fewer would be
aware of the potential for doing research using both
types of data linked together. The involvement of the
private sector in the use of health data alone is
already known to be a controversial topic. Other re-
search has found that 17% of the general public
would not accept commercial use of data at all [44]
and qualitative studies found that there is a belief in
a hidden agenda with commercial companies [31].
Linkage of supermarket loyalty cards with other
sources of lifestyle data has been proposed, for ex-
ample, as a resource for research into obesity [46].
Therefore, there is a need to understand further these
preferences of the public with regard to data linkage
at such scale, before this takes place.
For both countries, the least preferred option for the
profit attribute, compared to the base case, was that no-
body would profit. Profit by commercial companies, par-
ticularly large amounts of profit, is known to be of
particular concern to the public [13]. Many people are
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also concerned about the British government profiting
from selling health data to private healthcare compan-
ies [47]. Nonetheless, in this study, the preferred op-
tion was that profits be reinvested into the public
services, suggesting a very complex and nuanced set
of opinions and preferences around the creation and
use of profit from the use of health data, particularly
when commercial companies are involved. This has
been explored in detail by the Wellcome Trust [44]
and this study adds to that evidence base by quantify-
ing the preferences. However, it is acknowledged that
this study could not tease out the differences in re-
spondents’ preferences about how companies made
the profit described in the scenarios. For example, the
research mentioned in the scenario could have cre-
ated profit by sales of a newly developed healthcare
product or increased sales of an existing product, ei-
ther of which could deliver the levels used for the at-
tribute “the purpose of the research”.
The large numbers of respondents in both coun-
tries, and their representativeness in observable demo-
graphics to the overall national population, were key
strengths of the study. These substantial numbers
allowed comparisons across subgroups, showing dif-
ferences in acceptability of the worst-case scenario
between men and women and young and old. All re-
spondents were recruited using an internet panel pro-
vider to facilitate collecting a large study sample
relatively inexpensively. Although DCEs in healthcare
are increasingly administered online [48], the limita-
tions of using online surveys and/or internet panels
for stated preference studies has not been thoroughly
investigated. For instance, respondents to online DCEs
are more likely to be computer-literate and, particu-
larly in older age groups, may not be representative
of the general population. Their views could possibly
be different to those who would have preferred a
paper-based method. However, there is some evidence
suggesting online health surveys provide good quality
data compared with other methods such as postal
surveys or telephone interviews [49]. In addition, previous
DCEs using more population-representative sampling
frames (e.g. from the electoral roll) have resulted in
very low response rates, and hence had limited
representativeness and generalisability for different
reasons [50].
The DCE was restricted to those respondents who did
not believe the sharing and use of linked data should be
allowed under any circumstances. The choice to limit
the population in this way was made to ensure that we
could investigate the nuanced opinions of those who
agreed, in principle, to sharing and using linked data
[30]. Had those people been included, there was a risk
that those respondents would have selected the ‘opt-out’
option in every scenario. When a respondent chooses to
opt-out, nothing about their preferences are revealed as
there are no trade-offs with the attributes or levels pre-
sented in the hypothetical alternatives. For respondents
who did not believe the sharing and use of linked data
should be allowed under any circumstances, the option
to opt-out may have drawn disproportionately from the
other alternatives affecting the average and relative
choice shares presented in Fig. 2 [51]. Table 3 shows,
however, that there was not complete opposition to
sharing and using linked data. Respondents were not
aware that they would be routed-out of the DCE by an-
swering in a particular way, so there is no reason to
doubt their answers. In both jurisdictions, only small
numbers of respondents did not accept that research
should be conducted for one of the purposes presented
in the scenarios (the first question). Who the researchers
were and who was allowed to profit were much more
controversial topics, particularly in Sweden, with most
respondents being routed-out at these questions (Table
3). It is possible, therefore, that we were too risk averse
in excluding these respondents. In addition, the removal
of these individuals limits the generalisability of the
study findings. Future research may wish to extend the
study sample to include respondents who disagree with
the sharing and use of linked data in principle and inves-
tigate two-way or higher-order interactions between the
attribute levels by incorporating these into the experi-
mental design [28] to understand if certain combinations
result in more/less acceptable scenarios. There is also
the need for future qualitative investigations in Sweden
to understand why so many respondents had concerns
regarding sharing and using data, given how common-
place are the use of national registries.
Conclusion
This study suggests that the public living in Scotland
and Sweden are open to using anonymised linked
data in certain scenarios for research purposes but
some caution is advisable if health data are linked to
non-health data. Despite the use of linked data for
national registries being more common in Sweden,
replicating the Scottish DCE there has revealed sub-
stantial similarities in the preferences of the public in
the two jurisdictions. Given the considerable invest-
ment in data intensive health research and the use of
linked data in Scotland, this suggests there may be
considerable value in further comparative work be-
tween the two countries. In particular, further re-
search to understand the reasons underpinning public
concerns around data linkage and sharing in relation
to experiences in Sweden might be valuable to inform
the development of future practices in Scotland.
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Appendix
Random utility theory acknowledges that there is a
‘random’ component of utility that is unobserved by
the analyst, because it is due to unobservable factors
or just psychological impulse [52]. Therefore an
individual’s, n, utility, U, for alternative, j, can be de-
fined as:
Un; j ¼ Vn; j þ εn; j ð1Þ
Vn; j ¼ f βk ;Xn; j
  ð2Þ
Where Vn, j is the observed component of utility which
is a function of βk (the utility associated with the K attri-
butes and the level of that attribute (X)).
In this case, the utility function to be estimated is:
Un j ¼ αNonen j þ β1RUNIn j þ β2RUNHSn j
þ β3RUNHSGn j þ β4INHSn j þ β5INHSEn j
þ β6INHSEBn j þ β7BENEFITDn j
þ β8BENEFITGn j þ β9PROFITNn j
þ β10PROFITPUBn j þ β11PROFITNVn j
þ β12NONGOVn j þ β13PUBn j þ β14GOVn j þ εn j
ð3Þ
In Eq 3, β1 − 14 are preference weights associated with
each attribute level (as defined in Table 6), relative to
the base case (dropped). Note, βk assumes homogenous
preferences as it does not vary by n. The constant, α, re-
flects the utility associated with ‘opting-out’ with no data
linkage. The random component, εn, j, means U cannot
be perfectly observed.
Table 6 Attribute level coding
Attributes and levels Labels
The researchers are: Only university researchers RUNI
Only university researchers or NHS staff (researchers employed by a county council) RUNHS
Only university researchers, NHS staff or government researchers (researchers employed
by a county council or researchers employed by one of the authorities)
RUNHSG
University researchers, NHS staff, government researchers (researchers employed by a
county council or researchers employed by one of the authorities) and commercial
researchers such as market research organisations or pharmaceutical companiesa
RUNHSGP
The type of data being linked: Information from your GP (primary care) records being linked with information from
your other NHS (county council) health records e.g. hospital records
INHS
Information from your NHS (county council) health records being linked with information
from your social care or education records.
INHSE
Information from your NHS (county council) health records being linked with information
from your social care or education records, or from your employment and benefits (national
health insurance) records.
INHSEB
Information from your NHS (county council) health records being linked with information
from your social care, education, employment, and benefits (national health insurance)
records, as well as information collected about you in the private sector e.g. through online
shopping accountsa
INHSEBX
The purpose of the research: Research using linked information should only be conducted if it will have direct benefits for
the people whose information is being used.
BENEFITD
Research using linked information should only be conducted if it will have general public benefits. BENEFITG
Research using linked information should be allowed for any reason. a BENEFITX
Profit-Making: Nobody should be allowed to profit from research carried out using linked information. PROFITN
Any profit made from research carried out using linked information should be shared with the public. PROFITPUB
Any profit made from research carried out using linked information should be invested into
public services.
PROFITINV
Any profit made from research carried out using linked information should be kept by those carrying
out the research. a
PROFITR
Oversight: The process should be overseen by the Scottish (Swedish) Government. NONGOV
The process should be overseen by a non-governmental independent body (an independent body that
is not part of the Swedish Government).
PUB
The process should be overseen by the relevant public service(s); for example, research that uses
information from people’s health records should be overseen by the NHS (county council).
GOV
The process should be overseen by the organisations undertaking the researcha. ORG
aDefined as the base level for dummy coding of the categorical levels
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In the heteroskedastic conditional logit model the util-
ity function is estimated as
Un; j ¼ λnα1Nonen j þ λnβ1RUNIn j þ λnβ2RUNHSn j
þ λnβ3RUNHSGn j þ λnβ4INHSn j þ λnβ5INHSEn j
þλnβ6INHSEBn j þ λnβ7BENEFITDnj þ λnβ8BENEFITGnj
þ λnβ9PROFITNn j þ λnβ10PROFITPUBn j
þ λnβ11PROFITNVn j þ λnβ12NONGOVn j
þ λnβ13PUBn jSoctn þ λnβ14GOVn j þ λnα2Nonen jSoctn
þ λnβ15RUNIn jSoctn þ λnβ16RUNHSn jSoctn
þ λnβ17RUNHSGn jSoctn þ λnβ18INHSn jSoctn
þ λnβ19INHSEn jSoctn þ λnβ20INHSEBn jSoctn
þ λnβ21BENEFITDn jSoctn þ λnβ22BENEFITGn jSoctn
þ λnβ23PROFITNn jSoctn þ λnβ24PROFITPUBn jSoctn
þ λnβ25PROFITNVn jSoctn þ λnβ26NONGOVn jSoctn
þ λnβ27PUBn jSoctn þ λnβ28GOVn jSoctn þ εn j
ð4Þ
In Eq 4, Soctn is a dummy variable equal to 1 when
the respondent was Scottish and 0 when they were
Swedish. The dummy was interacted with each of the at-
tribute levels. Therefore β15 − 28 are the difference in
preference weights associated with each attribute level
due to being Scottish. Where λn is the relative scale par-
ameter for the Scottish sample relative to the Swedish
sample. HCL model parameterises λn as exp(Scot γ), and
therefore testing the significance of γ is testing if individ-
uals’ nationality had a statistically significant effect on
the scale parameter.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12911-020-01139-5.
Additional file 1. An interactive model showing average probability of
acceptability in different scenarios.
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